Optimizing Amorphous Solid Dispersion Formulation

April 1, 2013
AAPS News Magazine

Almost a third of new drug candidates require solubilization technology to achieve the best plasma exposure. As such, developing amorphous solid dispersion using a spry-drying process is an important topic. On December 13, 2012, David Vodak, vice president of chemistry, Bend Research, presented a webinar to AAPS members entitled, "Development of Amorphous Solid Dispersions Using the Spray-Drying Process: Early Development through Clinical Manufacture."